ExpreS2ion announces exercise of 2019 warrant program, second tranche of three
Hørsholm, Denmark, August 10, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces that 136,422 warrants held by employees under the 2019 Warrant Program (“TO2”) have been fully exercised, providing ExpreS2ion SEK 656,190. The exercise has increased the number of shares by 136,422 from 37,162,106 to 37,298,528.At an Extra General Meeting in ExpreS[2]ion held on May 23, 2019, it was resolved to issue warrants as part of an incentive program for employees (“the 2019 Warrant Program”, or “TO2”). The program comprised a total of 680,100 warrants, where one (1) warrant entitled to